Community Oncology Alliance

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Community Oncology Alliance

2023 Community Oncology Conference
2022 Community Oncology Advocacy Summit
2021 Community Oncology Conference
2022 Community Oncology Conference
Events

Playback speed

10 seconds

2021 Data on HCC & mCRC: Atezo+Bev vs. Sorafenib in Unresectable HCC; Pembro vs. Chemo for MMR/MSI-H CRC, Encorafenib+Cetuximab in BRAF V600E Mutations, Trastuzumab+Tucatinib for HER2-Amplified CRC

By 2021 Community Oncology Conference FEATURING Johanna Bendell

99 views

May 5, 2021

Comments 0

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss

Making the First Chance Count: Manuel

Feat. A. Ip

2021 Community Oncology Conference

Opportunities & Challenges in TNBC: Navigating Immune CPI Efficacy D…

2021 Community Oncology Conference

J. O'Shaughnessy

453 views

Advances in HER2+ BC: Overview of Current Data

2021 Community Oncology Conference

J. O'Shaughnessy

695 views

2021 Update on Frontline CLL: Comparing Treatment Outcomes With BTK …

2021 Community Oncology Conference

J. Sharman

19 views

2021 Update on Targeting Pathways in Frontline CLL: BTK Resistance, …

2021 Community Oncology Conference

J. Sharman

21 views

New Advances in KRASm NSCLC: Considering Sotorasib & Adagrasib Effic…

2021 Community Oncology Conference

A. Spira

242 views

2021 Update on EGFR Exon20ins in mNSCLC: Bispecific Antibody vs. TKI…

2021 Community Oncology Conference

A. Spira

132 views

2021 Data on HCC & mCRC: Atezo+Bev vs. Sorafenib in Unresectable HCC…

2021 Community Oncology Conference

J. Bendell

99 views

2021 Biliary Tract Cancer Updates: Ivosidenib in Chemo-Refractory ID…

2021 Community Oncology Conference

J. Bendell

227 views

2021 Pancreatic Cancer Updates: Preoperative mFOLFIRINOX vs. Gem/nab…

2021 Community Oncology Conference

J. Bendell

34 views

2021 GE Cancer Updates: Nivo for Stage 2/3 EC/GEJC, Chemo+/-Pembro i…

2021 Community Oncology Conference

J. Bendell

525 views

Guide to Current Biomarker Testing for GI Cancers and Improvements i…

2021 Community Oncology Conference

J. Bendell

59 views

New Coding & Reimbursement Changes in 2021: Best Practices, Medical …

2021 Community Oncology Conference

J. Blakely, R. Buell, B. Gamble, B. McAneny

40 views

How to Maximize Practice Efficiencies and Reduce Costs: What Your Pr…

2021 Community Oncology Conference

B. Gamble, M. Neubauer, T. O’Connell, A. Rahman

99 views

Hospital Drug Pricing: Is Pricing Transparency Going to Change the C…

2021 Community Oncology Conference

A. Gal

15 views

How Employers Approach Cancer Care & Benefit Design: Strategies, Bio…

2021 Community Oncology Conference

R. Baird, Jr., B. Jackson, R. Opdycke, C. Shaffer

13 views

Ensuring & Measuring Quality With a New Model for Cancer Care: Payme…

2021 Community Oncology Conference

M. Diaz, B. Gamble, L. Wilfong

11 views

Palliative Care in Oncology: Can It Improve QoL and Reduce the Use o…

2021 Community Oncology Conference

M. Rezaie

10 views

2021 IO & Gene Therapy Updates: Cancer Medicine and Vaccines in Deve…

2021 Community Oncology Conference

D. Spigel

17 views

2021 Updates on Theranostics in Oncology: How Do Diagnostic & Therap…

2021 Community Oncology Conference

T. Abraham

20 views

Biomarker Testing Updates: NGS vs. CGP, Who to Test, Predictive Biom…

2021 Community Oncology Conference

M. Dietrich, B. Green, G. Oxnard, A. Sireci, B. Yoon

398 views

Biosimilars in Cancer Care: Challenges & Opportunities From Research…

2021 Community Oncology Conference

E. Randolph Broun, S. Oskouei, K. Oubre, S. Parsad

9 views

COVID-19 Pandemic Management: How Has Cancer Care Evolved and Innova…

2021 Community Oncology Conference

L. Gordan, J. Perry, J. Pichoske

13 views